Antigen Presentation by Vascular Endothelial Cells and Epidermal Langerhans Cells: The Role of HLA‐DR

T and B lymphocytes apparently recognize antigen in two fundamentally different ways. B cell receptors (antibodies) can bind directly to free antigen, whereas the T cell receptor binds to antigen and cell surface markers on specialized accessory cells, generally designated antigen presenting cells. In humans these cell surface markersof importance for antigen activation of T cells are polymorphic membrance glycoproteins: the Class II HLA-DR molecules {Bergholtz & Thorsby 1977, Hansen et al. 1978, Hirschberg et al. 1979a), and perhaps the MT group of antigens (Thorsby et al. 1982). Antigen therefore most probably must be presented together in complexed form with Class li molecules on the surface of the antigen-presenting cells for T cell activation to occur. Antigen does not necessarily have to be presented together with self MHC molecules, but in certain experimental situations, only with the MHC products "seen" by the T cells at the time of initial sensitization (Thomas & Shevach 1977, Ishii et al. 1981). Additionally, after T cell binding to antigen-MHC complexes in the cell membrane, the antigen-presenting ceil produces a soluble Iymphokine now defined as Interleukin I (Il-I) which is necessary for futher T cell proliferation and differentiation (Blyden & Handschumacher 1977, Smith et al. 1980).

[1]  E. Thorsby,et al.  HLA‐D Region Molecules Restrict Proliferative T Cell Responses to Antigen , 1982, Immunological reviews.

[2]  R. Palacios Mechanism of T Cell Activation: Role and Functional Relationship of HLA‐DR Antigens and Interleukins , 1982, Immunological reviews.

[3]  E. Thorsby,et al.  Studies on Human Epidermal Langerhans Cells , 1982, Scandinavian journal of immunology.

[4]  A. Hamblin,et al.  Endothelial cell presentation of antigen to human T cells. , 1981, Human immunology.

[5]  H. Hirschberg,et al.  Antigen-presenting properties of human vascular endothelial cells: inhibition by anti-HLA-DR antisera. , 1981, Scandinavian journal of immunology.

[6]  E. Thorsby,et al.  Vascular and renal distribution of HLA--DR-like antigens. , 1981, Tissue antigens.

[7]  J. Klein,et al.  Responder T cells depleted of alloreactive cells react to antigen presented on allogeneic macrophages from nonresponder strains , 1981, The Journal of experimental medicine.

[8]  H. Hirschberg Presentation of viral antigens by human vascular endothelial cells in vitro. , 1981, Human immunology.

[9]  W. Baldwin,et al.  Antigens in human renal allografts. , 1981, Clinical immunology and immunopathology.

[10]  P. Lipsky,et al.  Human endothelial cell-lymphocyte interaction. Endothelial cells function as accessory cells necessary for mitogen-induced human T lymphocyte activation in vitro. , 1981, The Journal of clinical investigation.

[11]  E. Thorsby,et al.  Human endothelial cells can present antigen to sensitized T lymphocytes in vitro. , 1981, Transplantation proceedings.

[12]  F. Claas,et al.  Antibodies against donor antigens on endothelial cells and monocytes in eluates of rejected kidney allografts. , 2008, Tissue antigens.

[13]  E. Thorsby,et al.  HLA-D region products are expressed in endothelial cells. , 2008, Tissue antigens.

[14]  G. Stingl,et al.  Origin and Function of Epidermal Langerhans Cells , 1980, Immunological reviews.

[15]  L. Braathen Studies on human epidermal Langerhans cells , 1980, The British journal of dermatology.

[16]  E. Thorsby,et al.  Studies on human epidermal Langerhans' cells: II. Activation of human T lymphocytes to herpes simplex virus. , 1980, Acta dermato-venereologica.

[17]  E. Thorsby,et al.  Antigen-presenting properties of human vascular endothelial cells. , 1980, The Journal of experimental medicine.

[18]  R. Schwartz,et al.  Expression of leukemogenic recombinant viruses associated with a recessive gene in HRS/J mice , 1980, The Journal of experimental medicine.

[19]  R. Steinman,et al.  Dendritic cells of the mouse: identification and characterization. , 1980, The Journal of investigative dermatology.

[20]  M. Favata,et al.  The functional relationship of the interleukins , 1980, The Journal of experimental medicine.

[21]  E. Thorsby,et al.  HLA‐D/DR Restriction of Macrophage‐dependent Antigen Activation of Immune T Lymphocytes: Cross‐reacting Allogeneic HLA‐D/DR May Partly Substitute for Self HLA‐D/DR , 1980, Scandinavian journal of immunology.

[22]  E. Thorsby,et al.  Studies on Human Epidermal Langerhans Cells , 1980, Scandinavian journal of immunology.

[23]  L. Andersson,et al.  Expression of HLA‐ABC and ‐DR Locus Antigens on Human Kidney, Endothelial, Tubular and Glomerular Cells , 1980, Scandinavian journal of immunology.

[24]  E. Thorsby,et al.  The proliferative T cell response to herpes simplex virus (HSV) antigen is restricted by self HLA-D. , 1980, Clinical and Experimental Immunology.

[25]  D. Thomas,et al.  In vitro primary immunization of human peripheral blood lymphocytes to KLH: evidence for HLA-D-region restriction. , 1979, Transplantation proceedings.

[26]  E. Thorsby,et al.  Clonal distribution of HLA-restricted antigen-reactive T cells in man , 1979, The Journal of experimental medicine.

[27]  E. Thorsby,et al.  SPECIFIC DESTRUCTION OF HUMAN ENDOTHELIAL CELL MONOLAYERS BY ANTI‐DRw ANTISERA , 1979, Transplantation.

[28]  M. Mihm,et al.  Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response , 1979, The Journal of experimental medicine.

[29]  D. Gb,et al.  Antibodies directed against antigens on the endothelium of peritubular capillaries in patients with rejecting renal allografts. , 1979 .

[30]  L. van Es,et al.  ANTIBODIES DIRECTED AGAINST ANTIGENS ON THE ENDOTHELIUM OF PERITUBULAR CAPILLARIES IN PATIENTS WITH REJECTING RENAL ALLOGRAFTS , 1979, Transplantation.

[31]  J. D. de Vries,et al.  The role of monocytes in human lymphocyte activation by mitogens. , 1979, Journal of immunology.

[32]  P. Lincoln,et al.  Effect of ultraviolet light on dinitrochlorobenzene-specific antigen-presenting function. , 1978, Journal of immunology.

[33]  B. Rubin,et al.  Importance of HLA‐D antigens for the cooperation between human monocytes and T lymphocytes , 1978, European journal of immunology.

[34]  E. Thorsby,et al.  HLA‐D Restriction of the Macrophage‐Dependent Response of Immune Human T Lymphocytes to PPD in Vitro: Inhibition by Anti‐HLA‐DR Antisera , 1978, Scandinavian journal of immunology.

[35]  E. Thorsby,et al.  Macrophage‐Dependent Response of Immune Human T Lymphocytes to PPD In Vitro Influence of HLA‐D Histocompatibility , 1977, Scandinavian journal of immunology.

[36]  P. Stastny,et al.  A new antigen system expressed in human endothelial cells. , 1977, The Journal of clinical investigation.

[37]  P. A. Peterson,et al.  Epidermal Langerhans cells express Ia antigens , 1977, Nature.

[38]  M. G. Lewis,et al.  Ia antigen expression on human epidermal Langerhans cells , 1977, Nature.

[39]  E. Shevach,et al.  Nature of the antigenic complex recognized by T lymphocytes. IV. Inhibition of antigen-specific T cell proliferation by antibodies to stimulator macrophage Ia antigens. , 1977, Journal of immunology.

[40]  R. Handschumacher,et al.  Purification and properties of human lymphocyte activating factor (LAF). , 1977, Journal of immunology.

[41]  E. Jaffe Endothelial cells and the biology of factor VIII. , 1977, The New England journal of medicine.

[42]  P. Stastny,et al.  Eight groups of human endothelial cell alloantigens. , 1976, Tissue antigens.

[43]  E. Thorsby,et al.  THE HUMAN MIXED LYMPHOCYTE‐ENDOTHELIUM CULTURE INTERACTION , 1975, Transplantation.

[44]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.